Guelph, Canada

Adrian L Schwan



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Adrian L Schwan

Introduction

Adrian L Schwan is a notable inventor based in Guelph, Canada. He has made significant contributions to the field of synthetic lung surfactants, with a focus on improving treatments for lung tissue dysfunction. His work has led to the development of innovative compositions that have the potential to enhance respiratory therapies.

Latest Patents

Adrian L Schwan holds two patents related to synthetic lung surfactant compositions. His latest patents describe compositions that include phospholipase-resistant phospho-glycerol derivatives, phospholipase-resistant phospho-choline derivatives, and surface-active proteins or peptides. These compositions are designed to treat endogenous surfactant dysfunctional or deficient lung tissue. The patents also disclose the preparation of synthetic peptides for use in surfactant compositions and the delivery of therapeutic agents.

Career Highlights

Throughout his career, Adrian L Schwan has worked with prestigious institutions such as the University of Rochester and the University of Guelph. His research has focused on the development of synthetic lung surfactants, which are crucial for treating various lung conditions. His innovative approach has garnered attention in the scientific community.

Collaborations

Adrian has collaborated with notable colleagues, including Robert H Notter and Zhengdong Wang. These collaborations have contributed to the advancement of research in the field of lung surfactants and have helped in the development of effective therapeutic solutions.

Conclusion

Adrian L Schwan's contributions to the field of synthetic lung surfactants demonstrate his commitment to improving respiratory health. His innovative patents and collaborations highlight the importance of research in developing effective treatments for lung dysfunction.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…